CN1056142C - Anti-cancer medicine inula helianthus-aquatica lactone - Google Patents

Anti-cancer medicine inula helianthus-aquatica lactone Download PDF

Info

Publication number
CN1056142C
CN1056142C CN93100687A CN93100687A CN1056142C CN 1056142 C CN1056142 C CN 1056142C CN 93100687 A CN93100687 A CN 93100687A CN 93100687 A CN93100687 A CN 93100687A CN 1056142 C CN1056142 C CN 1056142C
Authority
CN
China
Prior art keywords
lactone
sunflower
aquatic
inula
aquatica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93100687A
Other languages
Chinese (zh)
Other versions
CN1089945A (en
Inventor
陈昆昌
胡美英
梁明达
贾伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL SCHOOL
Original Assignee
FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL SCHOOL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL SCHOOL filed Critical FIRST AFFILIATED HOSPITAL OF KUNMING MEDICAL SCHOOL
Priority to CN93100687A priority Critical patent/CN1056142C/en
Publication of CN1089945A publication Critical patent/CN1089945A/en
Application granted granted Critical
Publication of CN1056142C publication Critical patent/CN1056142C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to anticancer medicine inula helianthus-aquatica lactone, which is a white needle-shaped crystal with a melting point of 187 to 189 DEG C, a molecular formula of C17H22O5 and molecular weight of 306. The medicine is easily dissolved in chloroform, is slightly dissolved in ethyl ether, petroleum ether and alcohol and has obvious killing effect and growth inhibiting effect on cancer cells and leukemia cells of the lung, stomach, intestine, cervix, rhinopharynx, urinary bladder, etc. of a human body. The inula helianthus-aquatica lactone provided by the present invention is novel international-initiative anticancer medicine, has the advantages of good stability, strong anticancer effect, small toxicity and clinical trial and is anticancer medicine with good development prospects.

Description

The preparation method of aquatic-sunflower lactone
The present invention relates to a kind of is the preparation method that raw material extracts aquatic-sunflower lactone with the natural phant.
Cancer is the fiendish enemy who threatens the human life, and people are seeking effective medicine always for a long time, but do not search out good effect as yet and the little medicine of side effect so far.
The object of the present invention is to provide a kind of curative effect height, cancer therapy drug safe in utilization.
Cancer therapy drug name provided by the invention is called flower of Aquatic-sunflower Inula lactones (abbreviation compd A), and its chemical structure is:
Figure C9310068700031
This medicine is a kind of white, needle-shaped crystals, and fusing point 187-189 ℃, molecular formula C17H22O5 molecular weight 306 is soluble in chloroform, is dissolved in the ether of heat, in sherwood oil and the alcohol, and slightly soluble when cold.Be dissolved in alkali lye, add acid out and go out, Lei Mengde (Raymond) reagent is purple.Salt acid amide reacting positive.210nm has maximum absorption in ultraviolet.Infrared have ester and lactone and cyclopentanone absorption peak (1765,1735,1710,1670Cm -1).HNMR reaches 13C NMR DEPT spectrum shows 17 carbon and 22 hydrogen atom signals, by three methyl (one is acyl group), four methylene radical (one of them is terminal thiazolinyl); five methynes (wherein two combine with oxygen); and five quaternary carbons (a ketone carbon, two ester carbon, an olefinic carbon) are formed.Mass spectrum has provided 306 molecular weight, and pointing out this medicine is the sesqui terpene lactones.
1, the position of ethanoyl
After hydrolysis, the hydrolyzate Aa that gets deacetylate checks not had the acetyl base peak and hydroxyl peak (3490-3380 is strong) occurred through IR figure with compound.The nucleus magnetic resonance figure of Aa and A is found that relatively σ 5.51Hd moves to σ 4.15ppm to High-Field, and appearance can be by the hydroxyl peak σ 4.71HBr of heavy water conversion.Through the test of uncoupling, when irradiation σ 5.51HD peak, simplifying appears in σ 3.05ppm peak.When irradiation 3.05 peaks, changing all appears in peaks such as σ 4.5,5.5,5.9,6.15, thereby determines that ethanoyl is positioned at the C6 position, and the terminal thiazolinyl of σ 5.9,6.15 is positioned on the lactone ring C11 position.From C6 position hydrogen peak shape be the d peak as can be known the C5 position be quaternary carbon.
2, the position of ketone group
13C NMR spectrum has provided the ketone carbon peak of σ-218.2, IR (1735Cm -1) prompting has cyclopentanone in the molecule, therefore ketone group should be on the A ring, unimodal and coupling relation and the complexity supposition ketone group that splits branch be on the C3 position from the no 2H of hydrogen spectrum, and may be positioned on C2 or the C4, tests from uncoupling and know that the chemical shift of A ring hydrogen is all between σ 1.25-σ 2.23.When shining the methyl peak of σ 1.17, change all appears simplifying in peaks such as σ 1.5,1.7,2.3.And during the σ 5.5 of irradiation C6 position, do not have change substantially with the superiors.Compare A and approximate thing (1. chemical journal 41 (3): 254,1983 again; 2.J, arg, chem 39 (14): 2013,1974; 3.J, arg, chem 48:1356,1981:4.C.A81:63800d, 1974) carbon spectrum find that the chemical shift of compd A C5 position by low field, is σ 56.06.Show C5 except that being subjected to C8 position hydroxyl influences, neighbouring also have the group that influence is bigger.And the chemical shift of C1 position is σ 46.86, and therefore the compound displaced phase of not having a replacement with the C2 position seemingly think that ketone group is positioned at the C4 position.
3, mass spectrum, ultraviolet, infrared, it is as shown in the table for the nuclear-magnetism test data:
Table 1, ultra-violet absorption spectrum absorption peak and parsing tabulation
Compound maximum λnm minimum The absorption band ownership Remarks
Aquatic-sunflower lactone-A 210 Gamma lactone Dehydrated alcohol
Table 2, infrared absorption spectrum absorption peak and parsing tabulation
Absorption peak wave number Cm -1 Absorption peak strength Group and resonance-type Remarks
1765 1735 1710 1670 1460 1410 1280 1252 Strong strong and weak weak strong The two key gamma lactone OAC of gamma lactone cyclopentanone OAC KBr
Table 3 hydrolyzate Aa infrared absorption spectrum absorption peak and parsing tabulation
Absorption peak wave number Cm -1 Absorption peak strength Group and resonance-type Remarks
3540——3300 1765 1730 1625 1455 1400 1260 1240 Qiang Qiangqiang is strong OH gamma lactone cyclopentanone KBr
The absorption honeybee of table 4, hydrolyzate Aa ultra-violet absorption spectrum and parsing tabulation
Compound maximum λnm minimum The absorption band ownership Remarks
Aquatic-sunflower lactone-A 212 Gamma lactone Dehydrated alcohol
Table 5, hydrolyzate Aa's 13C nucleus magnetic resonance resolution table (400MHz heavy hydrogen pyridine)
The carbonatoms of compound Chemical shift σ ppm The DEPT spectrum Relevant hydrogen atom
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 45.50 24.76 44.40 220 57.41 74.79 53.61 77.76 39.11 30.17 141.14 169.93 119.58 19.02 19.97 CH CH CH CH C=O C CH CH CH CH C C CH CH CH 1-H 2-H 2 3-H 2 T T 6-H 7-H 8-H 9-H 2 10-H T 13-H 2 14-ME 15-ME
The proton nmr spectra resolution table instrument of table 6, compd A: Bruker-400 solvent: chloroform
Chemical shift σ ppm Number of hydrogen atoms Peak shape J=Hz Remarks
1.07 1.12 1.55 1.86 1.97 2.15 2.25 2.4 2.5 3.05 4.5 5.5 5.8 6.2 3H 3H 2H 1H 3H 2H 1H 1H 1H 1H 1H 1H 1H 1H S d m m s m T dd t m m d d J=3Hz d J=3Hz C15-H3 C14-H3 OAC C7-H C8-H C6-H C13-αH C13-βH
The mass-spectrometric data of table 7, compd A and resolution table
Mass-to-charge ratio (m/e) 307 284 246 173 119 97 43
Fragmention m +1 m-OAC
Remarks
Table 8, hydrolyzate Aa mass-spectrometric data and resolution table
Mass-to-charge ratio (m/e) 264 246
Fragmention m + m-H2O
Remarks
Table 9, compd A 13C nucleus magnetic resonance resolution table (400MHz chloroform)
The carbonatoms of compound Chemical shift σ ppm The DEPT spectrum Relevant hydrogen atom
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 46.66 24.49 44.40 218.2 56.06 74.84 52.77 76.24 37.85 30.08 137.46 169.26 121.94 18.42 19.95 169.49 21.05 CH CH2 CH2 C=O C CH CH CH CH2 CH C C=O CH2 CH3 CH3 C=O CH3 1-H 2-H2 3-H 6-H 7-H 8-H 9-H2 10-H 13α-H,13β-H 14-Me 15-Me 17-Me
Table 10, hydrolyzate Aa proton nmr spectra resolution table instrument: Bruker-400 solvent: heavy hydrogen pyridine
Chemical shift σ ppm Number of hydrogen atoms Peak shape J=Hz Remarks
0.93 1.02 1.25 1.41 1.66 1.91 2.22 2.33 3.15 4.15 4.54 4.7 6.01 6.23 3H 3H 1H 1H 1H 1H 1H 3H 1H 1H 1H 1H 1H 1H d s m q m m m m m α m Br α J=3Hz α J=3Hz C15-H3 C14-H3 OAC C7-H C8-H C8-H D2O disappearance C13-α H C13-β H
Embodiment: this compound can extract with following method: flower of Aquatic-sunflower Inula grass 1Kg (Inula helianthus Aquatica C ' Y ' Uu ex ling) is put in the apparatus,Soxhlet's, add sherwood oil (60-90 ℃) 2Kg, heat on the water-bath, refluxing extraction, there is crystallization to separate out when cold, filter,, promptly get the aquatic-sunflower lactone constituents through methyl alcohol recrystallization repeatedly, again through silica gel column layer (sample: silica gel=1: 200, the chloroform wash-out, the silica gel G thin-layer chromatography is checked (developping agent: chloroform, developer: Lei Mengde-Raymond reagent), merge same section, methanol crystallization can be got the aquatic-sunflower lactone that accounts for upper column quantity 90%, and the lactone yield can reach 3-5 ‰.
Pharmacodynamic study proves, in vitro tests: cancer cells such as people's lung, stomach, intestines, uterine neck, nasopharynx, bladder and leukemia cell are all had tangible lethal effect and growth-inhibiting effect, and ID30 is 0.1mg/kg, and ID50 is 1mg/kg, and ID90 is 4mg/kg.Recommending clinical consumption is 1mg/kg, and normal cell is not had obvious damaging action.In vivo test: to cancer in the mouse body, as ehrlich carcinoma, S180, U14, liver cancer, kinds of tumors such as carcinoma of the pancreas are all effective in cure, to ascites carcinoma curative effect P<0.01, solid carcinoma curative effect P<0.05.Administrations such as abdominal cavity, filling stomach, intramuscular injection are all effective, and effective dose iP is 30mg/kg, and im is 30mg/kg, and Po is 200mg/kg.
Safety research: toxicologic study proves, mouse LD50ip is 270mg/kg, po is 1400mg/kg, acute chronic toxicity and the long term toxicity test of rat and dog are not seen blood picture, the heart, liver, renal function and marrow, the toxic reaction of brain etc. can cause blood pressure drops for the quick intravenous injection of dog, but available metaraminol and ephedrine is prevented and treated effectively, wherein three dogs respectively repeat three tests, each one month at interval, to test dosage (in a day) at every turn and reach into dosage 10 times, off-test is for the third time put to death, core, liver, spleen, kidney, organs and tissues paraffin wax cut sections for microscopic examination such as lung, no abnormality seen changes, and result of study proves that flower of Aquatic-sunflower Inula lactones provided by the invention is the PTS of international initiative, have and have good stability, have cancer suppressing action, and toxicity is little, can try out in clinical.It is a kind of cancer therapy drug with fine DEVELOPMENT PROSPECT.

Claims (3)

1, a kind of name is called aquatic-sunflower lactone, structural formula is
Figure C9310068700021
The preparation method of compound, it is characterized in that may further comprise the steps:
1. be raw material with flower of Aquatic-sunflower Inula grass (Inula helianthus Aquatica C ' Y ' Uu ex ling), the flower of Aquatic-sunflower Inula grass heated with sherwood oil that service temperature is 60~90 ℃;
2. refluxing extraction has crystallization to separate out when cold;
3. filter,, promptly get the aquatic-sunflower lactone constituents with methyl alcohol recrystallization repeatedly;
4. separate through silica gel column chromatography, chloroform wash-out, silica gel G thin-layer chromatography are checked, merge same section again, and methanol crystallization obtains required product.
2, according to the process of claim 1 wherein that the 1. described flower of Aquatic-sunflower Inula grass of step and the weight ratio of sherwood oil are 1: 2.
3, according to the process of claim 1 wherein that the 4. described silica gel column chromatography of step is a sample: silica gel=1: 200.
CN93100687A 1993-01-04 1993-01-04 Anti-cancer medicine inula helianthus-aquatica lactone Expired - Fee Related CN1056142C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN93100687A CN1056142C (en) 1993-01-04 1993-01-04 Anti-cancer medicine inula helianthus-aquatica lactone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN93100687A CN1056142C (en) 1993-01-04 1993-01-04 Anti-cancer medicine inula helianthus-aquatica lactone

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN 99108173 Division CN1112182C (en) 1999-06-11 1999-06-11 Medical application of aquatic-sunflower lactone

Publications (2)

Publication Number Publication Date
CN1089945A CN1089945A (en) 1994-07-27
CN1056142C true CN1056142C (en) 2000-09-06

Family

ID=4983179

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93100687A Expired - Fee Related CN1056142C (en) 1993-01-04 1993-01-04 Anti-cancer medicine inula helianthus-aquatica lactone

Country Status (1)

Country Link
CN (1) CN1056142C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1067552C (en) * 1994-12-06 2001-06-27 大连医科大学 Method for extracting lipid anti-cancer medicine from liver
CN1062866C (en) * 1997-10-31 2001-03-07 中国人民解放军第二军医大学药学院 Bryostatin as anti-cancer active compound
CA2438932A1 (en) * 2001-02-21 2002-09-06 Rutgers, The State University Of New Jersey Compositions and methods for cancer prevention and treatment derived from inula britannica
CN101890065B (en) * 2010-06-17 2013-04-17 昆明医科大学第一附属医院 Inula flower injection and preparation method thereof
CN102000066B (en) * 2010-09-26 2012-07-25 中国科学院昆明植物研究所 Inula helianthus-aquatica extract, anti-tumor medicament using same as active ingredient, preparation method and application thereof
CN110563679B (en) * 2019-08-21 2021-07-13 中山大学 Sesquiterpene lactone compound, preparation method thereof and application of sesquiterpene lactone compound in preparation of medicine for preventing and treating nasopharyngeal carcinoma

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5549369A (en) * 1978-10-04 1980-04-09 Nippon Kayaku Co Ltd Antitumorigenic substance
EP0098041A2 (en) * 1982-05-19 1984-01-11 R.P. Scherer Corporation Sesquiterpene lactones, extracts containing them, their preparation and pharmaceutical use
JPS617201A (en) * 1984-06-20 1986-01-13 Sumitomo Chem Co Ltd Fungicide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5549369A (en) * 1978-10-04 1980-04-09 Nippon Kayaku Co Ltd Antitumorigenic substance
EP0098041A2 (en) * 1982-05-19 1984-01-11 R.P. Scherer Corporation Sesquiterpene lactones, extracts containing them, their preparation and pharmaceutical use
JPS617201A (en) * 1984-06-20 1986-01-13 Sumitomo Chem Co Ltd Fungicide

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C.A.VOL.106,NO.15 1987.4.3 OVEZDUTDYEV,A.ET AL "THE STRUCTURE OF ERGOLIDE";C.A.VOL.112,NO.15 1990.3.26 RUSTAIYAN A.ET AL A SECO-GUAIANOLIDE AND OTHER SESQUITERPENE LACTONE FROM POSTIA BOBYCINA" *
C.A.VOL.106,NO.15 1987.4.3 OVEZDUTDYEV,A.ET AL "THE STRUCTURE OF ERGOLIDE" *
C.A.VOL.112,NO.15 1990.3.26 RUSTAIYAN A.ET AL A SECO-GUAIANOLIDE AND OTHER SESQUITERPENE LACTONE FROM POSTIA BOBYCINA" *

Also Published As

Publication number Publication date
CN1089945A (en) 1994-07-27

Similar Documents

Publication Publication Date Title
FUJITA et al. Fungal metabolites. Part 12. Potent immunosuppressant, 14-deoxomyriogin,(2s, 3r, 4r-(e) 2-amino-3, 4-dihydroxy-2-hydroxymethyleicos-6-enoic acid and structure-activity relationships of myriocin derivatives
EP2223929A1 (en) Gambogic glycoside derivatives and analogs, the preparation and the application thereof
Lei et al. Synthesis and anti-tumor activity of 14-O-derivatives of natural oridonin
CN1056142C (en) Anti-cancer medicine inula helianthus-aquatica lactone
WO2012033266A1 (en) Novel artemisinin or deoxoartemisinin-glycolipid hybrid derivatives and antiangiogenic use thereof
Hatano et al. Tannins of Coriaria japonica A. Gray. I.: Coriariins A and B, new dimeric and monomeric hydrolyzable tannins
CN101613388A (en) The coumarin kind compound of glucuronidation and application thereof
Wong et al. Isolation, structural elucidation, and chemical synthesis of 2-hydroxy-3-octadecyl-5-methoxy-1, 4-benzoquinone (irisoquin), a cytotoxic constituent of Iris missouriensis
CN1112182C (en) Medical application of aquatic-sunflower lactone
CN110903241B (en) Separation and purification method of water-soluble catechol tetrahydroisoquinoline alkaloid
EP2486026B1 (en) Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer
EP2520580B1 (en) Halogenated dideoxy saccharide derivatives, preparation method and use thereof
CN109206469B (en) Glycyrrhetinic acid derivative and preparation method and application thereof
Hatano et al. Camptothins A and B: New Dimeric Hydrolyzable Tannins from Camptotheca acuminata DECNE.
FI98889C (en) A method for preparing an antineoplastic drug derived from a plant extract
LIN et al. Tannins and related compounds. XCVIII.: Structures of three new dimeric ellagitannins, excoecarianin and excoecarinins A and B, isolated from the leaves of Excoecaria kawakamii Hayata
Liu et al. Dihydromyricetin from Ampelopsis grossedentata and its derivatives: Structural characterization and anti-hepatocellular carcinoma activity
Oliveira et al. Design, synthesis, and antitumor evaluation of novel anthraquinone derivatives
CN108752404B (en) A kind of berberine salt derivative and its preparation method and application that triazole is sugar-modified
Ohmoto et al. Constituents of Hibiscus moscheutos L. I
CN114149400B (en) Preparation and application of gentisic acid mixed source hetero-terpenoid compound in sarcandra glabra
CN115010773B (en) Eugenol glycosyl thiourea derivative, preparation method and application thereof
CN110003291B (en) Fluoro glycosyl modified taxol compound and synthesis method and application thereof
CN114644673A (en) Estradiol derivative, preparation method and medical application thereof
Cui et al. Sulfoglycolipid from the marine brown alga Sargassum Hemiphyllum

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20000906

Termination date: 20110104